Altered alanine aminotransferase and γ-glutamyl transpeptidase in women with history of preeclampsia: Association with waist-to-hip ratio and body mass index

European Journal of Gastroenterology and Hepatology

Volumn 21, Issue 2, 2009, Pages 196-200

  Portelinha, Ana ^a,b   Cerdeira, Ana Sofia ^c   Belo, Luis ^a,b   Tejera, Eduardo ^b   Pinto, Fátima ^d   Pinto, Ana ^d   Rebelo, Irene ^a,b  

^a UNIVERSITY OF PORTO   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

^c HOSPITAL DE SANTO ANTÓNIO   (Portugal)

^d Department of Obstetrics Maternidade Julio Dinis ^*  (Portugal)

Author keywords

Body mass index; Hypertension; Liver; Preeclampsia

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; C REACTIVE PROTEIN; GAMMA GLUTAMYLTRANSFERASE;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANAMNESIS; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD LEVEL; BLOOD SAMPLING; BODY MASS; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ENZYMATIC ASSAY; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; PHYSICAL EXAMINATION; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; WAIST HIP RATIO; ANTHROPOMETRY; BLOOD; BLOOD PRESSURE; ENZYMOLOGY; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; YOUNG ADULT;

ADULT; ALANINE TRANSAMINASE; ANTHROPOMETRY; ASPARTATE AMINOTRANSFERASES; BLOOD PRESSURE; BODY MASS INDEX; C-REACTIVE PROTEIN; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; PRE-ECLAMPSIA; PREGNANCY; WAIST-HIP RATIO; YOUNG ADULT;

EID: 59149091557     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MEG.0b013e32831d81a7     Document Type: Article

References (26)

1. Guntupalli SR, Steingrub J. Hepatic disease and pregnancy: an overview of diagnosis and management Crit Care Med 2005; 33 (Suppl 10): S332-S339.
2. Duley L, Meher S, Abalos E. Management of pre-eclampsia. Br Med J 2006; 332:463-468.
3. Rahman TM, Wendon J. Severe hepatic dysfunction in pregnancy. Q J Med 2002; 95:343-357.
4. Barron WM. The syndrome of preeclampsia. Gastroenterol Clin North Am 1992; 21:851-872.
5. Burroughs AK Pregnancy and liver disease. Forum (Genova) 1998; 8: 42-58.
6. Hunt CM, Sharara Al. Liver disease in pregnancy. Am Fam Physician 1999; 59:829-836.
7. Burroughs AK, Seong NH, Dojcinov DM, Scheuer PJ, Sherlock SV. Idiopathic acute fatty liver of pregnancy in 12 patients. Q J Med 1982; 51:481-497.
8. Rebelo I, Carvalho-Guerra F, Pereira-Leite L, Quintanilha A. Comparative study of lactoferrin and other blood markers of inflammatory stress between preeclamptic and normal pregnancies. Eur J Obstet Gynecol Reprod Biol 1996; 64:167-173.
9. Lawlor DA, Sattar N, Smith GD, Ebrahim S. The associations of physical activity and adiposity with alanine aminotransferase and gamma- glutamyltransferase. Am J Epidemiol 2005; 161:1081-1088.
10. Gortney JS, Sanders RM. Impact of C-reactive protein on treatment of patients with cardiovascular disease. Am J Health Syst Pharm 2007; 64:52009-2016.
11. Belo L, Santos-Silva A, Rocha S, Caslake M, Cooney J, Pereira-Leite L, et al. Fluctuations in C-reactive protein concentration and neutrophil activation during normal human pregnancy. Eur J Obstet Gynecol Reprod Biol 2005; 123:46-51.
12. Dekker GA, Sibai BM. Etiology and pathogenesis of preeclampsia: current concepts. Am J Obstet Gynecol 1998; 179:1359-1375.
13. Smith GC, Pell JP, Walsh D. Pregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129 290 births. Lancet 2001; 357:2002-2006.
14. Balderas-Peña LM, Canales-Muñoz JL, Angulo-Vázquez J, Anaya-Prado R, González Ojeda A. The HELPP syndrome - evidence of a possible systemic inflammatory response in pre-eclampsia? Ginecol Obstet Mex 2002; 70:328-337.
15. Kim JH, Kwon CI, Ko EH, Kim DY, Kim HY, Jung SH, et al. Abnormal liver function tests in pregnancy: a single institution experience. Korean J Gastroenterol 2007; 50:36-41.
16. Hay JE. Liver disease in pregnancy. Hepatology 2008; 47:1067-1076.
17. Kaaja R, Kinnunen T, Luoto R. Regional differences in the prevalence of pre-eclampsia in relation to the risk factors for coronary artery disease in women in Finland. Eur Heart J 2005; 26:44-50.
18. Wolf M, Hubel CA, Lam C, Sampson M, Ecker JL, Ness RB, et al. Preeclampsia and future cardiovascular disease: potential role of altered angiogenesis and insulin resistance. J Clin Endocrinol Metab 2004; 89:6239-6243.
19. Sattar N, Scherbakova O, Ford I, O'Reilly DS, Stanley A, Forrest E, et al. Elevated alanine aminotransferase predicts new-onset type 2 diabetes independently of classical risk factors, metabolic syndrome, and C-reactive protein in the west of Scotland coronary prevention study. Diabetes 2004; 53:2855-2860.
20. Tiikkainen M, Bergholm R, Rissanen A, Aro A, Salminen I, Tamminen M, et al. Effects of equal weight loss with orlistat and placebo on body fat and serum fatty acid composition and insulin resistance in obese women. Am J Clin Nutr 2004; 79:22-30.
21. Chan DC, Barrett HP, Watts GF. Dyslipidemia in visceral obesity: mechanisms, implications, and therapy. Am J Cardiovasc Drugs 2004; 4:227-246.
22. Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB. Elevated C-reactive protein levels in overweight and obese adults. JAMA 1999; 282:2131-2135.
23. Du Clos TW. Function of C-reactive protein. Ann Med 2000; 32:274-278.
24. Güilcan E, Gulcan A, Erbilen E, Taser F, Sahin L, Ozbek O, Bicik Z. The predictive value of CRP levels on future severe renal disease in overweight and obese subjects without diabetes mellitus and hypertension. Am J Med Sci 2007; 334:444-451.
25. Qiu C, Luthy DA, Zhang C, Walsh SW, Leisenring WM, Wlliams MA. A prospective study of maternal serum C-reactive protein concentrations and risk of preeclampsia. Am J Hypertens 2004; 17:154-160.
26. Vickers M, Ford I, Morrison R, Prescott G, Watson S, Hannaford P, et al. Markers of endothelial activation and atherothrombosis in women with history of preeclampsia or gestational hypertension. Thromb Haemost 2003; 90:1192-1197.